SEC 13F Intelligence

Argyle Capital Management, LLC / MRK

Argyle Capital Management, LLC’s Merck & Co Inc Position

Does Argyle Capital Management, LLC own Merck & Co Inc (MRK)? Yes — 62.8K shares worth $8M (+2.46% of its 13F portfolio) as of Q1 2026, down from 63.5K shares the prior filed quarter.

Position Value
$8M
Q1 2026
Shares
62.8K
% of Portfolio
+2.46%
Quarters Held
30
currently held

Position History MRK

Reported value by quarter
Q4 ’18: $7MQ4 ’18Q1 ’19: $8MQ2 ’19: $8MQ3 ’19: $7MQ4 ’19: $8MQ4 ’19Q1 ’20: $7MQ2 ’20: $7MQ3 ’20: $7MQ4 ’20: $7MQ4 ’20Q1 ’21: $6MQ2 ’21: $7MQ3 ’21: $6MQ4 ’21: $6MQ4 ’21Q1 ’22: $6MQ2 ’22: $7MQ3 ’22: $7MQ4 ’22: $8MQ4 ’22Q1 ’23: $8MQ2 ’23: $8MQ3 ’23: $7MQ4 ’23: $7MQ4 ’23Q1 ’24: $8MQ2 ’24: $7MQ3 ’24: $6MQ4 ’24: $6MQ4 ’24Q1 ’25: $5MQ2 ’25: $5MQ3 ’25: $5MQ4 ’25: $7MQ4 ’25Q1 ’26: $8Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202662.8K$8M+2.46%
Q4 202563.5K$7M+2.23%
Q3 202559.9K$5M+1.74%
Q2 202559.3K$5M+1.70%
Q1 202559.6K$5M+1.99%
Q4 202458.1K$6M+2.28%
Q3 202453.6K$6M+2.43%
Q2 202456.7K$7M+2.89%
Q1 202460.4K$8M+3.08%
Q4 202362.5K$7M+2.82%
Q3 202371.7K$7M+2.71%
Q2 202371.9K$8M+2.99%
Q1 202374.8K$8M+2.80%
Q4 202276.3K$8M+2.91%
Q3 202277.8K$7M+2.61%
Q2 202278.0K$7M+2.55%
Q1 202277.7K$6M+2.08%
Q4 202184.1K$6M+2.01%
Q3 202184.1K$6M+2.09%
Q2 202184.1K$7M+2.11%
Q1 202184.2K$6M+2.19%
Q4 202084.2K$7M+2.56%
Q3 202085.1K$7M+2.89%
Q2 202087.2K$7M+2.83%
Q1 202087.5K$7M+3.18%
Q4 201987.7K$8M+2.83%
Q3 201988.6K$7M+2.82%
Q2 201990.3K$8M+2.87%
Q1 201991.5K$8M+2.92%
Q4 201891.6K$7M+2.97%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Argyle Capital Management, LLC’s full portfolio or all institutional holders of MRK.